Objective: Capecitabine combined with docetaxel have demonstrated antitumor synergy for non-small cell lung cancer (NSCLC). Due to absence of phase I trial in C
Objective: The aim of the study was to compare the effects of several kinds of diagnosis and treatment measures on hilar cholangiocarcinoma. Methods: The 136 pa